ABT vs DMLP · P/E 25, rev $44.33B vs P/E 13, rev $56.1M
Abbott Laboratories (ABT) versus Dorchester Minerals LP (DMLP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Dorchester Minerals LP (DMLP) is a oil & gas e&p company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported DMLP revenue for 2026-06-30 was $56.1M. Net income was $30.9M. Revenue was down 4.8% from 2026-03-31 to 2026-06-30. DMLP currently screens at market cap $1.29B and trailing P/E 13.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. DMLP currently screens at market cap $1.29B and trailing P/E 13.3.
Not investment advice. Open the ABT and DMLP stock pages for the full models.
Not investment advice.